Singapore HSA
Material regulatory developments from Health Sciences Authority are tracked daily by Cresthaven Analytics. Over the last 90 days, 20 material briefs relevant to professionals operating in the healthcare & life sciences sector have been published below. Each brief is sourced directly from the primary regulatory feed, summarized for institutional readers, and scored for materiality.
Recent material activity
A selection of recent published briefs; this is not a complete archive.
HSA charges Singapore male for trafficking etomidate vaporiser pods under tobacco control statute
Singapore's Health Sciences Authority (HSA) charged Ho Joo Hong, 41, on 15 September 2026 with trafficking etomidate vaporiser pods — the first publicly recorded prosecution of this substance-delivery combination under t…
Read the full Singapore HSA brief →HSA orders retail-level recall of NU SKIN ageLOC Dermatic Effects across all batches due to undisclosed theophylline
Singapore's Health Sciences Authority (HSA) has directed a retail-level recall of NU SKIN ageLOC Dermatic Effects, covering all batches, after detecting theophylline in the product. Theophylline is not an approved cosmet…
Read the full Singapore HSA brief →HSA mandates labeling updates for all Singapore-registered levodopa combination products over vitamin B6 deficiency and seizure risk
Singapore's Health Sciences Authority (HSA) issued a safety communication on 15 September 2026 requiring updated package inserts for all 14 locally registered carbidopa/levodopa and benserazide/levodopa products. The upd…
Read the full Singapore HSA brief →HSA mandates labeling updates for levodopa combination products over vitamin B6 deficiency and seizure risk
Singapore's Health Sciences Authority (HSA) issued a safety communication on September 15, 2026 directing label updates for all locally registered carbidopa/levodopa and benserazide/levodopa products. The update adds war…
Read the full Singapore HSA brief →HSA charges 17-year-old with trafficking 1,264 etomidate vaporiser pods under Singapore's vaporiser control statute
Singapore's Health Sciences Authority (HSA) charged a 17-year-old male on 4 September 2026 with trafficking etomidate vaporiser pods intercepted at Tuas Checkpoint. The charge is brought under the Tobacco and Vaporisers …
Read the full Singapore HSA brief →Singapore Parliament tables Bill consolidating health regulatory functions under HSA in two phases
Singapore's Ministry of Health and Health Sciences Authority have jointly tabled the Health Sciences Authority (Amendment) and Other Matters Bill for Second Reading on 9 September 2026. The Bill establishes HSA as Singap…
Read the full Singapore HSA brief →HSA warns against adulterated weight loss product containing sibutramine and five prescription-grade ingredients sold on Shopee and Lazada
The Health Sciences Authority (HSA) issued a public safety alert on September 8, 2026 against 'Dermcare weight (D30 & Sstrong Set) Daily Health Support Set.' Laboratory testing confirmed the product contains sibutramine,…
Read the full Singapore HSA brief →HSA charges five individuals for alleged trafficking of etomidate vaporiser pods in Singapore enforcement action
Singapore's Health Sciences Authority has filed criminal charges against five men for alleged trafficking of etomidate vaporiser pods. One individual was apprehended in possession of pods valued at approximately SGD 870,…
Read the full Singapore HSA brief →HSA orders batch recall of Medicube PDRN Pink Collagen Capsule Cream after Sudan IV detected in two Venus Beauty lots
Singapore's Health Sciences Authority issued a recall instruction on 26 August 2026 covering two specific batches of Medicube PDRN Pink Collagen Capsule Cream sold by Venus Beauty Pte. Ltd. after laboratory testing detec…
Read the full Singapore HSA brief →HSA orders retail-level recall of two Medicube PDRN Pink Collagen Capsule Cream batches over Sudan IV contamination
Singapore's Health Sciences Authority (HSA) issued a retail-level recall on August 28, 2026 covering two batches of Medicube PDRN Pink Collagen Capsule Cream. The recall was triggered by detection of Sudan IV, a prohibit…
Read the full Singapore HSA brief →HSA launches fee-waiver registration pathway for clinically important unregistered medical devices on Special Access Route
The Health Sciences Authority announced on 28 August 2026 a Registration Support Initiative for unregistered medical devices. The initiative waives evaluation fees for eligible devices to ease the transition from the Spe…
Read the full Singapore HSA brief →HSA orders wholesale-level recall of Carbimazole 5 Tablet 5 mg on out-of-specification stability findings
Singapore's Health Sciences Authority issued a wholesale-level recall of Carbimazole 5 Tablet 5 mg on August 26, 2026. The recall was triggered by out-of-specification results identified during a stability study.
Read the full Singapore HSA brief →HSA orders retail-level recall of Fludeoxyglucose F-18 Injection over failed radiochemical purity test
Singapore's Health Sciences Authority (HSA) issued a retail-level recall on August 21, 2026 for Fludeoxyglucose F-18 Injection 5, 20mCi/ml, a radiopharmaceutical used in PET imaging. The recall followed a failed radioche…
Read the full Singapore HSA brief →HSA charges Singapore male with etomidate vaporiser pod trafficking under the Tobacco and Vaporisers Control Act
The Health Sciences Authority charged Tan Jun Yuan, Jovan, age 31, in court on 12 August 2026 for alleged trafficking of etomidate vaporiser pods under the Tobacco and Vaporisers Control Act 1993, which classifies etomid…
Read the full Singapore HSA brief →HSA issues public advisory prohibiting unauthorised ivermectin use for unproven conditions including COVID-19 and cancer
Singapore's Health Sciences Authority (HSA) issued an advisory on 19 August 2026 directing the public against purchasing, importing, or using ivermectin for unproven indications. The advisory reaffirms ivermectin's presc…
Read the full Singapore HSA brief →HSA orders retail-level recall of B. Braun Ibuprofen Solution for Infusion 4mg/ml over out-of-specification impurity results
Singapore's Health Sciences Authority issued a retail-level recall of B. Braun Ibuprofen Solution for Infusion 4mg/ml on August 18, 2026, after out-of-specification impurity results were identified during a stability stu…
Read the full Singapore HSA brief →HSA orders retail-level recall of Guardian Skin Relief Calamine Lotion over out-of-specification cadmium content
Singapore's Health Sciences Authority issued a retail-level recall on 14 August 2026 for one batch of Guardian Skin Relief Calamine Lotion. The recall was triggered by cadmium content exceeding specification limits in th…
Read the full Singapore HSA brief →HSA publishes finalised Best Practices Guide for Medical Device Cybersecurity following public consultation
Singapore's Health Sciences Authority published the finalised Best Practices Guide for Medical Device Cybersecurity on 14 August 2026. The guide incorporates feedback from a public consultation that ran from 10 March to …
Read the full Singapore HSA brief →HSA mandates extended post-treatment contraception period for CellCept from 6 weeks to 6 months
Singapore's Health Sciences Authority published a Dear Healthcare Professional Letter on 13 August 2026 requiring an updated contraception duration for CellCept (mycophenolate mofetil). The change extends the post-treatm…
Read the full Singapore HSA brief →HSA charges Singapore resident with trafficking etomidate vaporiser pods under the Tobacco and Vaporisers Control Act
Singapore's Health Sciences Authority charged Dean Daniel Ong, 23, in court on 31 July 2026 for alleged trafficking of etomidate vaporiser pods. The charge follows a residential enforcement operation that yielded two vap…
Read the full Singapore HSA brief →
Get every Singapore HSA brief delivered the day it lands
From $149/month
Cresthaven Analytics monitors Health Sciences Authority continuously, applying institutional materiality scoring to every release. Subscribers receive structured briefs via email, portal, and (Professional tier and above) real-time alerts.
View all tiers →